These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9365776)
1. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. Carr A; Brown D; Cooper DA AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776 [No Abstract] [Full Text] [Related]
2. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir]. Rickerts V; Kober A; Stille W Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567 [No Abstract] [Full Text] [Related]
3. Paronychia in association with indinavir treatment. Colson AE; Sax PE; Keller MJ; Turk BK; Pettus PT; Platt R; Choo PW Clin Infect Dis; 2001 Jan; 32(1):140-3. PubMed ID: 11118393 [TBL] [Abstract][Full Text] [Related]
5. [Nephropathy caused by crystal deposits induced by indinavir]. Gonzalo A Nefrologia; 2001; 21(4):337. PubMed ID: 11816506 [No Abstract] [Full Text] [Related]
6. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released]. Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575 [No Abstract] [Full Text] [Related]
7. Subtle occurrence of indinavir-induced acute renal insufficiency. Viganò A; Rombolà G; Barbiano di Belgioioso G; Sala N; Principi N AIDS; 1998 May; 12(8):954-5. PubMed ID: 9631152 [No Abstract] [Full Text] [Related]
9. Indinavir--effect on sugar and insulin. TreatmentUpdate; 2001 Jun; 13(2):7-8. PubMed ID: 11570290 [No Abstract] [Full Text] [Related]
10. Ritonavir and indinavir one year later. TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094 [No Abstract] [Full Text] [Related]
11. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients. Chang ES; Tetreault DD; Liu YT; Beall GN J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549 [No Abstract] [Full Text] [Related]
12. The choice of HIV protease inhibitor: indinavir is currently the best option. Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067 [TBL] [Abstract][Full Text] [Related]
13. [A 36-year-old woman with HIV infection and abdominal distension]. López García F; Mora Rufete A; Padilla Urrea S; Gutiérrez Rodero F Rev Clin Esp; 1999 Aug; 199(8):533-4. PubMed ID: 10522436 [No Abstract] [Full Text] [Related]
14. Risk factors for ritonavir intolerance and outcome after change to indinavir. Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044 [No Abstract] [Full Text] [Related]
15. Using ritonavir with indinavir in cases of virologic failure. TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095 [No Abstract] [Full Text] [Related]
19. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079 [TBL] [Abstract][Full Text] [Related]
20. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis. Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]